Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome

  Free Subscription


15.10.2018

1 Adv Ther
2 Aliment Pharmacol Ther
1 Allergo J Int
1 Biol Res Nurs
1 Biomedicines
1 Clin Exp Gastroenterol
1 Clin Gastroenterol Hepatol
1 Curr Med Res Opin
1 Curr Opin Pharmacol
1 Endocrinol Diabetes Nutr
1 Eur J Radiol
1 FEMS Microbiol Lett
1 J Inflamm Res
1 J Pain Res
1 J Pediatr Gastroenterol Nutr
1 JCI Insight
1 Life Sci
1 Medicine (Baltimore)
1 Minerva Gastroenterol Dietol
2 Neurogastroenterol Motil
1 Nutrients
1 Parasitol Res
1 Psychosom Med
1 Therap Adv Gastroenterol
1 Trials
1 Turk J Gastroenterol
1 United European Gastroenterol J
1 World J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Ther

  1. WEERTS ZZRM, Keszthelyi D, Vork L, Aendekerk NCP, et al
    A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.
    Adv Ther. 2018 Oct 4. pii: 10.1007/s12325-018-0802.
    PubMed     Text format     Abstract available


    Aliment Pharmacol Ther

  2. RIBOLSI M, Cicala M, Zentilin P, Neri M, et al
    Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Aliment Pharmacol Ther. 2018 Oct 7. doi: 10.1111/apt.14986.
    PubMed     Text format     Abstract available

  3. FORD AC, Harris LA, Lacy BE, Quigley EMM, et al
    Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2018 Oct 8. doi: 10.1111/apt.15001.
    PubMed     Text format     Abstract available


    Allergo J Int

  4. REESE I, Schafer C, Kleine-Tebbe J, Ahrens B, et al
    Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunolog
    Allergo J Int. 2018;27:147-151.
    PubMed     Text format     Abstract available


    Biol Res Nurs

  5. HAN CJ, Jarrett ME, Cain KC, Jun S, et al
    Association of Fatigue With TPH2 Genetic Polymorphisms in Women With Irritable Bowel Syndrome.
    Biol Res Nurs. 2018 Oct 11:1099800418806055. doi: 10.1177/1099800418806055.
    PubMed     Text format     Abstract available


    Biomedicines

  6. COBOS C, Bansal PS, Jones L, Wangchuk P, et al
    Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold.
    Biomedicines. 2018;6.
    PubMed     Text format     Abstract available


    Clin Exp Gastroenterol

  7. CHANG C
    Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin.
    Clin Exp Gastroenterol. 2018;11:335-345.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  8. OSADCHIY V, Martin CR, Mayer EA
    The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications.
    Clin Gastroenterol Hepatol. 2018 Oct 4. pii: S1542-3565(18)31081.
    PubMed     Text format     Abstract available


    Curr Med Res Opin

  9. OLDEN KW, Chey WD, Shringarpure R, Nicandro JP, et al
    Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
    Curr Med Res Opin. 2018 Oct 8:1-29. doi: 10.1080/03007995.2018.1533456.
    PubMed     Text format     Abstract available


    Curr Opin Pharmacol

  10. MANNING LP, Biesiekierski JR
    Use of dietary interventions for functional gastrointestinal disorders.
    Curr Opin Pharmacol. 2018;43:132-138.
    PubMed     Text format     Abstract available


    Endocrinol Diabetes Nutr

  11. AGUILAR-AGUILAR E, Marcos-Pasero H, de la Iglesia R, Espinosa-Salinas I, et al
    Characteristics and determinants of dietary intake and physical activity in a group of patients with multiple chemical sensitivity.
    Endocrinol Diabetes Nutr. 2018 Oct 8. pii: S2530-0164(18)30193.
    PubMed     Text format     Abstract available


    Eur J Radiol

  12. MENYS A, Saliakellis E, Borrelli O, Thapar N, et al
    The evolution of magnetic resonance enterography in the assessment of motility disorders in children.
    Eur J Radiol. 2018;107:105-110.
    PubMed     Text format     Abstract available


    FEMS Microbiol Lett

  13. DOGAN B, Belcher-Timme HF, Dogan EI, Jiang ZD, et al
    Evaluation of Escherichia coli pathotypes associated with Irritable Bowel Syndrome.
    FEMS Microbiol Lett. 2018 Oct 8. pii: 5123711. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Inflamm Res

  14. NG QX, Soh AYS, Loke W, Lim DY, et al
    The role of inflammation in irritable bowel syndrome (IBS).
    J Inflamm Res. 2018;11:345-349.
    PubMed     Text format     Abstract available


    J Pain Res

  15. LIN MJ, Yu BP
    Upregulation of the high-affinity choline transporter in colon relieves stress-induced hyperalgesia.
    J Pain Res. 2018;11:1971-1982.
    PubMed     Text format     Abstract available


    J Pediatr Gastroenterol Nutr

  16. ZEEVENHOOVEN J, Rutten JMTM, van Dijk M, Peeters B, et al
    Parental Factors in Pediatric Functional Abdominal Pain Disorders: A Cross-Sectional Cohort Study.
    J Pediatr Gastroenterol Nutr. 2018 Oct 4. doi: 10.1097/MPG.0000000000002163.
    PubMed     Text format     Abstract available


    JCI Insight

  17. GRUNDY L, Harrington AM, Castro J, Garcia-Caraballo S, et al
    Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction.
    JCI Insight. 2018;3.
    PubMed     Text format     Abstract available


    Life Sci

  18. RAWLA P, Sunkara T, Raj JP
    Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome.
    Life Sci. 2018 Oct 2. pii: S0024-3205(18)30618-0. doi: 10.1016/j.lfs.2018.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  19. WEN W, Zhang H, Shen J, Wei L, et al
    Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol.
    Medicine (Baltimore). 2018;97:e12661.
    PubMed     Text format     Abstract available


    Minerva Gastroenterol Dietol

  20. PAULS RN, Max JB
    Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a United States National survey.
    Minerva Gastroenterol Dietol. 2018 Oct 2. pii: S1121-421X.18.02518.
    PubMed     Text format     Abstract available


    Neurogastroenterol Motil

  21. RUSSELL JP, Mohammadi E, Ligon C, Latorre R, et al
    Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations.
    Neurogastroenterol Motil. 2018 Oct 12:e13479. doi: 10.1111/nmo.13479.
    PubMed     Text format     Abstract available

  22. SHULMAN RJ, Ohman L, Stridsberg M, Cain K, et al
    Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.
    Neurogastroenterol Motil. 2018 Oct 9:e13486. doi: 10.1111/nmo.13486.
    PubMed     Text format     Abstract available


    Nutrients

  23. CHUN E, Yoon S, Parveen A, Jin M, et al
    Alleviation of Irritable Bowel Syndrome-Like Symptoms and Control of Gut and Brain Responses with Oral Administration of Dolichos lablab L. in a Mouse Model.
    Nutrients. 2018;10.
    PubMed     Text format     Abstract available


    Parasitol Res

  24. GONZALEZ-ARENAS NR, Villalobos G, Vargas-Sanchez GB, Avalos-Galarza CA, et al
    Is the genetic variability of Cathepsin B important in the pathogenesis of Blastocystis spp.?
    Parasitol Res. 2018 Oct 8. pii: 10.1007/s00436-018-6103.
    PubMed     Text format     Abstract available


    Psychosom Med

  25. SODERQUIST F, Sundberg I, Ramklint M, Widerstrom R, et al
    The Relationship Between Daytime Salivary Melatonin and Gastrointestinal Symptoms in Young Adults Seeking Psychiatric Care.
    Psychosom Med. 2018 Oct 6. doi: 10.1097/PSY.0000000000000644.
    PubMed     Text format     Abstract available


    Therap Adv Gastroenterol

  26. YIANNAKOU Y, Agrawal A, Allen PB, Arebi N, et al
    UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation.
    Therap Adv Gastroenterol. 2018;11:1756284818798791.
    PubMed     Text format     Abstract available


    Trials

  27. RUMSEY P, Waseem M, Pei LX, Geng H, et al
    Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial.
    Trials. 2018;19:529.
    PubMed     Text format     Abstract available


    Turk J Gastroenterol

  28. SAHIN-ERYILMAZ G, Basak K, Cakir-Madenci O, Koc H, et al
    Relationship between irritable bowel syndrome and plasma and tissue ghrelin levels.
    Turk J Gastroenterol. 2018 Oct 5. doi: 10.5152/tjg.2018.17593.
    PubMed     Text format     Abstract available


    United European Gastroenterol J

  29. CARD T, Enck P, Barbara G, Boeckxstaens GE, et al
    Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey.
    United European Gastroenterol J. 2018;6:1245-1253.
    PubMed     Text format     Abstract available


    World J Gastroenterol

  30. BOULETE IM, Thadi A, Beaufrand C, Patwa V, et al
    Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models.
    World J Gastroenterol. 2018;24:1888-1900.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: